S‐100B as an extra selection tool for FDG PET/CT scanning in follow‐up of AJCC stage III melanoma patients

BACKGROUND AND OBJECTIVES: This current study assessed the value of S‐100B measurement to guide fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scanning for detecting recurrent disease in stage III melanoma patients. METHODS: This study included 100 stage III melan...

Descripción completa

Detalles Bibliográficos
Autores principales: Deckers, Eric A., Wevers, Kevin P., Muller Kobold, Anneke C., Damude, Samantha, Vrielink, Otis M., van Ginkel, Robert J., Been, Lukas B., van Leeuwen, Barbara L., Hoekstra, Harald J., Kruijff, Schelto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851671/
https://www.ncbi.nlm.nih.gov/pubmed/31468535
http://dx.doi.org/10.1002/jso.25682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851671/
https://www.ncbi.nlm.nih.gov/pubmed/31468535
http://dx.doi.org/10.1002/jso.25682

Ejemplares similares